ZOFRAN AND BIRTH DEFECTS

Studies have shown an association between the use of Zofran and birth defects. Zofran is a drug approved by the FDA in 1991 as an anti-nausea drug for patients with cancer treatments or post-surgery. Manufacturer GlaxoSmithKline's ("GSK") drug, Zofran, however, was used "off-label" with pregnant women to aid in morning sickness. This use was not approved by the FDA. Studies associating the drug and or its generic version with birth defects have shown results ranging from birth defects being 30% more likely to twice as likely and up to more than four times as likely. Generic drug manufacturers began selling the drug after GSK lost its patent in 2006.

If you or a loved one took Zofran in the first trimester of pregnancy and the child had a birth defect, please contact me. There is no charge for the consultation, and any lawsuit filed would be on a contingent fee basis wherein you would owe no attorney fee unless there was a recovery. Use the CONTACT function on this website or e-mail me at james@jjpettitlaw.com.